These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16108100)

  • 21. The diversity of GABA(A) receptor subunit distribution in the normal and Huntington's disease human brain.
    Waldvogel HJ; Faull RL
    Adv Pharmacol; 2015; 73():223-64. PubMed ID: 25637443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intense dopamine innervation of the subventricular zone in Huntington's disease.
    Bédard C; Wallman MJ; Pourcher E; Parent A; Parent M
    Neuroreport; 2010 Dec; 21(17):1074-9. PubMed ID: 20926973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External evaluation of a deep learning-based approach for automated brain volumetry in patients with huntington's disease.
    Haase R; Lehnen NC; Schmeel FC; Deike K; Rüber T; Radbruch A; Paech D
    Sci Rep; 2024 Apr; 14(1):9243. PubMed ID: 38649395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal distribution in the putamen in Huntington's disease.
    Roos RA; Pruyt JF; de Vries J; Bots GT
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):422-5. PubMed ID: 3158722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear membrane indentations in Huntington's chorea.
    Roos RA; Bots GT
    J Neurol Sci; 1983 Sep; 61(1):37-47. PubMed ID: 6226764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The subependymal layer in rodents: a site of structural plasticity and cell migration in the adult mammalian brain.
    Peretto P; Merighi A; Fasolo A; Bonfanti L
    Brain Res Bull; 1999 Jul; 49(4):221-43. PubMed ID: 10424843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.
    Huang Q; Zhou D; Sapp E; Aizawa H; Ge P; Bird ED; Vonsattel JP; DiFiglia M
    Neuroscience; 1995 Mar; 65(2):397-407. PubMed ID: 7777157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.
    Thu DC; Oorschot DE; Tippett LJ; Nana AL; Hogg VM; Synek BJ; Luthi-Carter R; Waldvogel HJ; Faull RL
    Brain; 2010 Apr; 133(Pt 4):1094-110. PubMed ID: 20375136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A progressive and cell non-autonomous increase in striatal neural stem cells in the Huntington's disease R6/2 mouse.
    Batista CM; Kippin TE; Willaime-Morawek S; Shimabukuro MK; Akamatsu W; van der Kooy D
    J Neurosci; 2006 Oct; 26(41):10452-60. PubMed ID: 17035529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's disease.
    Phillips W; Morton AJ; Barker RA
    Neuroreport; 2006 Oct; 17(15):1623-7. PubMed ID: 17001281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.
    Nana AL; Kim EH; Thu DC; Oorschot DE; Tippett LJ; Hogg VM; Synek BJ; Roxburgh R; Waldvogel HJ; Faull RL
    J Huntingtons Dis; 2014; 3(1):45-64. PubMed ID: 25062764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization.
    Ferrante RJ; Kowall NW; Cipolloni PB; Storey E; Beal MF
    Exp Neurol; 1993 Jan; 119(1):46-71. PubMed ID: 8432351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle re-entry of neurons and reactive neuroblastosis in Huntington's disease: Possibilities for neural-glial transition in the brain.
    Manickam N; Radhakrishnan RK; Vergil Andrews JF; Selvaraj DB; Kandasamy M
    Life Sci; 2020 Dec; 263():118569. PubMed ID: 33049278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study.
    Augood SJ; Faull RL; Love DR; Emson PC
    Neuroscience; 1996 Jun; 72(4):1023-36. PubMed ID: 8735227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide alterations in the infundibular nucleus of Huntington's disease patients.
    van Wamelen DJ; Aziz NA; Anink JJ; Roos RA; Swaab DF
    J Neuroendocrinol; 2013 Feb; 25(2):198-205. PubMed ID: 22928483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.
    Hirano M; Iritani S; Fujishiro H; Torii Y; Habuchi C; Sekiguchi H; Yoshida M; Ozaki N
    Neuropathology; 2019 Oct; 39(5):331-341. PubMed ID: 31264738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE; Landis DM; Zalneraitis EL
    Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease.
    Ferrante RJ; Beal MF; Kowall NW; Richardson EP; Martin JB
    Brain Res; 1987 May; 411(1):162-6. PubMed ID: 2955849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.